Drug Manufacturing and Formulation Program (DMFP)
Award Notice Posted
- Solicitation number
- 75N95024R00077
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Awarded
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N98026D00015-75N98026F00001
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Place of performance
- Menlo Park, California, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse, part of the National Institutes of Health under the Department of Health and Human Services, awarded an IDIQ contract to SRI International on May 4, 2026, for the Drug Manufacturing and Formulation Program with a $49,999,999 ordering value.
The contract runs from May 4, 2026, through May 3, 2036. Four IDIQ awards were issued concurrently under this procurement, each with the same $49,999,999 ceiling. SRI International received the first task order effective May 4, 2026, through July 3, 2026, in the firm-fixed price amount of $5,000. The award was made under unrestricted competition with no set-aside applied.
Notice text
Four (4) Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts with a maximum ordering value of $49,999,999.00 and an ordering period from May 4, 2026 through May 3, 2036, were awarded on May 4, 2026. Concurrently, the first task orders were issued to each awardee with an effective date of May 4, 2026 through July 3, 2026, in the firm-fixed price amount totaling $5,000.00.
Awarded contract 75N98026D00015 to SRI INTERNATIONAL for 49999999.00 on 2026-05-04.
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Award Notice | |
| Drug Manufacturing and Formulation Program (DMFP) | Solicitation | |
| Drug Manufacturing and Formulation Program (DMFP) | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | No set-aside | |
| Synthesis and Distribution of Drugs of Abuse and Related Compounds | National Institute on Drug Abuse | Total Small Business |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity